• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

David B. Nash, MD, professor of health policy and chairman, department of health policy, Jefferson Medical College, Jefferson University


David B. Nash, MD, is on the front lines of DM with his academic institution's sponsorship of the Population Health Colloquium, a leading forum in chronic care and DM.

David B. Nash, MD, MBA
Dr. Raymond C. and Doris N. Grandon Professor of Health Policy
Chairman, Department of Health Policy
Jefferson Medical College, Jefferson University
Philadelphia, Pa.

"We are trying to bring academic rigor to DM and to host informed debate," Dr. Nash says.

Dr. Nash is a Phi Beta Kappa graduate of Vassar College, where he received a B.A. degree in economics. He earned his medical degree from the University of Rochester (N.Y.) School of Medicine and Dentistry and an MBA degree in health administration from the Wharton School, University of Pennsylvania.

He was also named a 2004 Managed Healthcare Executive Leader in Disease Management.

Related Content
© 2024 MJH Life Sciences

All rights reserved.